Document is current
Any future updates will be listed below
-
Authors
Yan, Hao
Tan, Xiaoqing https://orcid.org/0000-0002-1475-8125
Zou, Siyuan https://orcid.org/0009-0005-7771-3644
Sun, Yihong https://orcid.org/0009-0004-8715-624X
Ke, Ailong https://orcid.org/0000-0001-5957-7822
Tang, Weixin https://orcid.org/0000-0002-5739-5416
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM118174)
American Cancer Society (RSG-22-043-01-ET)
David and Lucile Packard Foundation (2022-74685)
- License Information
-
More Information
Article History
Received: 2 August 2023
Accepted: 7 June 2024
First Online: 8 July 2024
Competing interests
: The University of Chicago and Cornell University filed provisional patent applications (63/523,862 and 63/523,884) on the engineered IscB–ωRNA systems and their applications for programmed genome editing. These patent applications are pending and the inventors are W.T., H.Y. and A.K. The other authors declare no competing interests.
